title: Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma.
authors.affiliation: Research Institute, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Takami
authors.forename: Y
authors.initials: Y
authors.lastname: Takata
authors.forename: K
authors.initials: K
authors.lastname: Matsumoto
authors.forename: S
authors.initials: S
authors.lastname: Ono
authors.forename: W
authors.initials: W
authors.lastname: Tsukada
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000032:analysis / Q000097:blood; D000818:Animals; D000941:Antigens; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D016084:Bronchoconstriction / Q000187:drug effects; D006168:Guinea Pigs; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects / Q000503:physiopathology*; D010047:Ovalbumin; D013764:Tetrahydronaphthalenes / Q000494:pharmacology / Q000627:therapeutic use*; D013929:Thromboxane B2 / Q000032:analysis / Q000097:blood; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
chemical_list: D000941:Antigens; D007093:Imidazoles; D013764:Tetrahydronaphthalenes; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D010047:Ovalbumin; C056295:nafagrel; D013930:Thromboxane-A Synthase